Displaying 10 out of 28 results

  1. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche's Tecentriq recommended for EU approval to treat lung cancer form

    The European Medicine Agency's Committee for Medicinal Products for Human Use has recommended EU approval of Roche's cancer immunotherapy ...
  2. New Content Item

    When hurricanes halt treatment, lung cancer patients die sooner

  3. A lit cigarette burns in Sydney, Australia

    Lung cancer screening guidelines may miss more African Americans at risk

    Current lung cancer screening guidelines may need to be less restrictive when it comes to African American smokers, a new study suggests.
  4. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda sets new five-year survival standard for advanced lung cancer

    Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive ...
  5. New Content Item

    More evidence welding fumes raise lung cancer risk

  6. The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co

    Lilly's combo therapy succeeds in late-stage lung cancer study

    Eli Lilly and Co said on Tuesday that its combo treatment, Cyramza, met the main goal in a late-stage study in patients with a form of lung cancer.
  7. FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel

    Roche gets European approval for Tecentriq combo vs. lung cancer

    Roche has received European Commission approval for its Tecentriq drug in combination with Avastin and chemotherapy as an initial treatment for ...
  8. New Content Item

    Clinigen agrees to buy US rights to Novartis' cancer drug Proleukin

  9. New Content Item

    AbbVie halts late-stage trial for lung cancer drug Rova-T